SAS Output

S1609 FAQ

UPCOMING DART COHORT CLOSURES AS OF 25-APR-2019 6:10 AM

The REPORT Procedure

Detailed and/or summarized report

Table 1

# COHORT Name Up-coming
Closure Date
Closure Type
  No up-coming closures to report    

CLOSED DART COHORTS AS OF 25-APR-2019 6:10 AM

The REPORT Procedure

Detailed and/or summarized report

Table 1

Closure Type # COHORT NAME TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
# of
ACT.
INSTs
# of
CURR
IRBs
Permanent Close 1 Epithelial tumors of nasal cavity, sinuses, nasopharynx 7 0 0 0 0 0 316 156
Permanent Close 2 Epithelial tumors of major salivary glands 31 1 0 0 0 0    
Permanent Close 3 Salivary gland type tumors of head and neck, lip, esophagus, stomach, trachea and lung, breast and other location 7 2 0 0 0 0    
Temporary Close 4 Undifferentiated carcinoma of gastrointestinal (GI) tract 7 5 1 0 0 0    
Permanent Close 5 Adenocarcinoma with variants of small intestine 25 7 0 0 0 0    
Permanent Close 6 Squamous cell carcinoma with variants of GI tract (stomach small intestine, colon, rectum, pancreas) 6 0 0 0 0 0    
Permanent Close 7 Fibromixoma and low grade mucinous adenocarcinoma (pseudomixoma peritonei) of the appendix and ovary 10 0 0 0 0 0    
Temporary Close 8 Rare Pancreatic tumors including acinar cell carcinoma, mucinous cystadenocarcinoma or serous cystadenocarcinoma 11 4 0 0 0 0    
Permanent Close 9 Intrahepatic cholangiocarcinoma 9 0 0 0 0 0    
Permanent Close 10 Extrahepatic cholangiocarcinoma and bile duct tumors 10 0 0 0 0 0    
Temporary Close 11 Sarcomatoid carcinoma of lung 7 4 4 2 1 0    
Temporary Close 12 Bronchoalveolar carcinoma lung (a.k.a. adenocarcinoma in situ, minimally invasive adenocarcinoma, lepidic predominant adenocarcinoma, or invasive mucinous adenocarcinoma) 6 2 0 0 0 0    
Permanent Close 13 Non-epithelial tumors of the ovary 25 0 0 0 0 0    
Permanent Close 14 Trophoblastic tumor 3 1 0 0 0 0    
Permanent Close 15 Transitional cell carcinoma other than that of the renal, pelvis, ureter, or bladder 1 0 0 0 0 0    
Temporary Close 16 Cell tumor of the testes and extragonadal germ tumors 17 7 7 3 0 0    
Permanent Close 20 Adenocarcinoma with variants of GU system (excluding prostate cancer) 9 0 0 0 0 0    
Permanent Close 22 Endocrine carcinoma of pancreas and digestive tract 12 0 0 0 0 0    
Permanent Close 23 Neuroendocrine carcinoma including carcinoid of the lung 35 2 0 0 0 0    
Temporary Close 24 Pheochromocytoma, malignant 7 2 1 0 0 0    
Permanent Close 25 Paraganglioma 6 3 0 0 0 0    
Temporary Close 26 Carcinomas of pituitary gland, thyroid gland parathyroid gland and adrenal cortex 14 0 0 0 0 0    
Permanent Close 28 Peripheral nerve sheath tumors and NF1-related tumors 9 0 0 0 0 0    
Permanent Close 29 Malignant giant cell tumors 3 2 1 1 0 0    
Permanent Close 30 Chordoma 11 3 0 0 0 0    
Permanent Close 31 Adrenal cortical tumors 21 11 0 0 0 0    
Permanent Close 32 Tumor of unknown primary (Cancer of Unknown Primary; CuP) 21 0 0 0 0 0    
Permanent Close 33 Not Otherwise Categorized (NOC) Rare Tumors, after discussion with Study Chairs 127 21 0 0 0 0    
Permanent Close 34 Adenoid cystic carcinoma 27 1 0 0 0 0    
Temporary Close 35 Vulvar cancer 9 0 0 0 0 0    
Temporary Close 36 MetaPLASTIC carcinoma (of the breast) 19 12 11 5 2 0    
Permanent Close 37 Gastrointestinal stromal tumor (GIST) 12 0 0 0 0 0    

DART ACCRUAL REPORT

The REPORT Procedure

Detailed and/or summarized report

Table 1

Status # COHORT NAME TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
# of
ACT.
INSTs
# of
CURR
IRBs
Permanent Close 1 Epithelial tumors of nasal cavity, sinuses, nasopharynx 7 0 0 0 0 0 316 156
Permanent Close 2 Epithelial tumors of major salivary glands 31 1 0 0 0 0    
Permanent Close 3 Salivary gland type tumors of head and neck, lip, esophagus, stomach, trachea and lung, breast and other location 7 2 0 0 0 0    
Temporary Close 4 Undifferentiated carcinoma of gastrointestinal (GI) tract 7 5 1 0 0 0    
Permanent Close 5 Adenocarcinoma with variants of small intestine 25 7 0 0 0 0    
Permanent Close 6 Squamous cell carcinoma with variants of GI tract (stomach small intestine, colon, rectum, pancreas) 6 0 0 0 0 0    
Permanent Close 7 Fibromixoma and low grade mucinous adenocarcinoma (pseudomixoma peritonei) of the appendix and ovary 10 0 0 0 0 0    
Temporary Close 8 Rare Pancreatic tumors including acinar cell carcinoma, mucinous cystadenocarcinoma or serous cystadenocarcinoma 11 4 0 0 0 0    
Permanent Close 9 Intrahepatic cholangiocarcinoma 9 0 0 0 0 0    
Permanent Close 10 Extrahepatic cholangiocarcinoma and bile duct tumors 10 0 0 0 0 0    
Temporary Close 11 Sarcomatoid carcinoma of lung 7 4 4 2 1 0    
Temporary Close 12 Bronchoalveolar carcinoma lung (a.k.a. adenocarcinoma in situ, minimally invasive adenocarcinoma, lepidic predominant adenocarcinoma, or invasive mucinous adenocarcinoma) 6 2 0 0 0 0    
Permanent Close 13 Non-epithelial tumors of the ovary 25 0 0 0 0 0    
Permanent Close 14 Trophoblastic tumor 3 1 0 0 0 0    
Permanent Close 15 Transitional cell carcinoma other than that of the renal, pelvis, ureter, or bladder 1 0 0 0 0 0    
Temporary Close 16 Cell tumor of the testes and extragonadal germ tumors 17 7 7 3 0 0    
Open 17 Epithelial tumors of penis - squamous adenocarcinoma cell carcinoma with variants of penis 16 9 9 5 1 0    
Open 18 Squamous cell carcinoma variants of the genitourinary (GU) system 7 3 1 1 0 0    
Open 19 Spindle cell carcinoma of kidney, pelvis, ureter 3 0 0 0 0 0    
Permanent Close 20 Adenocarcinoma with variants of GU system (excluding prostate cancer) 9 0 0 0 0 0    
Open 21 Odontogenic malignant tumors 4 0 0 0 0 0    
Permanent Close 22 Endocrine carcinoma of pancreas and digestive tract 12 0 0 0 0 0    
Permanent Close 23 Neuroendocrine carcinoma including carcinoid of the lung 35 2 0 0 0 0    
Temporary Close 24 Pheochromocytoma, malignant 7 2 1 0 0 0    
Permanent Close 25 Paraganglioma 6 3 0 0 0 0    
Temporary Close 26 Carcinomas of pituitary gland, thyroid gland parathyroid gland and adrenal cortex 14 0 0 0 0 0    
Open 27 Desmoid tumors 11 1 1 1 0 0    
Permanent Close 28 Peripheral nerve sheath tumors and NF1-related tumors 9 0 0 0 0 0    
Permanent Close 29 Malignant giant cell tumors 3 2 1 1 0 0    
Permanent Close 30 Chordoma 11 3 0 0 0 0    
Permanent Close 31 Adrenal cortical tumors 21 11 0 0 0 0    
Permanent Close 32 Tumor of unknown primary (Cancer of Unknown Primary; CuP) 21 0 0 0 0 0    
Permanent Close 33 Not Otherwise Categorized (NOC) Rare Tumors, after discussion with Study Chairs 127 21 0 0 0 0    
Permanent Close 34 Adenoid cystic carcinoma 27 1 0 0 0 0    
Temporary Close 35 Vulvar cancer 9 0 0 0 0 0    
Temporary Close 36 MetaPLASTIC carcinoma (of the breast) 19 12 11 5 2 0    
Permanent Close 37 Gastrointestinal stromal tumor (GIST) 12 0 0 0 0 0    
    TOTAL 565 103 36 18 4 0